Objective To observe the curative effect of diltiazem combined with low molecular weight heparins on chronic pulmonary heart disease (CPHD).
目的观察地尔硫联合低分子肝素治疗慢性肺源性心脏病的疗效。
Included in the options are low molecular weight heparins (LMWHs), synthetic pentasaccharides, adjusted-dose warfarin, aspirin, and mechanical prophylaxis.
包括低分子肝素（LMWHs），合成的戊多糖，调整剂量的华法林，阿斯匹林以及物理预防措施。
Methods Compare the effect on anticoagulant therapy, hemodialysis and the side effect from the use of heparin with those from the use of Low Molecular Weight Heparins.
方法：对比使用肝素与使用低分子肝素在血液透析中的抗凝效果，透析效果及其副作用。
AIM: To investigate the effects and safe of low molecular weight heparins (LMWH) in the treatment of patients with chronic pulmonary heart diseases (CPHD) at hypercoagulability state.
目的：观察低分子肝素(LMWH)治疗慢性肺源性心脏病合并高凝状态的疗效和安全性。
AIM: To investigate the effects and safe of low molecular weight heparins (LMWH) in the treatment of patients with chronic pulmonary heart diseases (CPHD) at hypercoagulability state.
目的：观察低分子肝素(LMWH)治疗慢性肺源性心脏病合并高凝状态的疗效和安全性。
应用推荐